About
Acs Biotech develops regenerative medicine products for cartilage repair using a patented 3D hydrogel chitosan matrix to support chondrocyte implantation via minimally invasive surgery, and also provides high-quality osteoarticular cells for research and development.
Explore Acs Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.